aspirin has been researched along with Hematuria in 39 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Hematuria: Presence of blood in the urine.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Results show the short-term risk of hemorrhage in treating patients with acute transient ischemic attack (TIA) or minor acute ischemic stroke (AIS) with clopidogrel plus aspirin or aspirin alone." | 9.30 | Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial. ( Barsan, W; Easton, JD; Elm, JJ; Farrant, M; Johnston, SC; Kim, AS; Lindblad, AS; Palesch, YY; Tillman, H, 2019) |
| "To investigate the results of evaluations in patients presenting with gross hematuria while receiving anticoagulant or aspirin treatment and to compare the source of bleeding in these respective groups." | 7.70 | Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment. ( Avidor, Y; Matzkin, H; Nadu, A, 2000) |
| "Clopidogrel and ticagrelor are rarely reported to cause vasculitis via drug hypersensitivity reaction, largely mediated by T cells and immunoglobulin E (IgE)." | 5.41 | Refractory drug-induced systemic small-vessel vasculitis with two varied extracutaneous manifestations: a case report and review of the literature. ( Jovanovic, M; Sabovic, M, 2023) |
| "Results show the short-term risk of hemorrhage in treating patients with acute transient ischemic attack (TIA) or minor acute ischemic stroke (AIS) with clopidogrel plus aspirin or aspirin alone." | 5.30 | Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial. ( Barsan, W; Easton, JD; Elm, JJ; Farrant, M; Johnston, SC; Kim, AS; Lindblad, AS; Palesch, YY; Tillman, H, 2019) |
| "Taking aspirin does not increase the risk of hematuria and hematospermia after TRUS-PB." | 5.12 | Safety of transrectal ultrasound-guided prostate biopsy in patients receiving aspirin: An update meta-analysis including 3373 patients. ( Chen, C; Chen, D; Liu, G; Liu, Y; Luo, Z; Xie, Y, 2021) |
| "Warfarin, aspirin, and the combination of these, have all proven to be efficacious in preventing future events after myocardial infarction." | 5.12 | Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis. ( Arnesen, H; Eikvar, L; Hurlen, M; Seljeflot, I, 2006) |
| "The aim of this systematic review and meta-analysis was to understand whether continued aspirin therapy is a risk factor for bleeding complications after ultrasound-guided biopsy of the prostate." | 4.87 | Transrectal ultrasound-guided prostate biopsies in patients taking aspirin for cardiovascular disease: A meta-analysis. ( Bozzini, G; Carmignani, L; Gaeta, M; Negri, E; Pavesi, M; Picozzi, S; Ricci, C, 2011) |
| "To investigate the results of evaluations in patients presenting with gross hematuria while receiving anticoagulant or aspirin treatment and to compare the source of bleeding in these respective groups." | 3.70 | Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment. ( Avidor, Y; Matzkin, H; Nadu, A, 2000) |
| "The proportion of men still reporting hematospermia at 30 days after PB was 21." | 2.73 | Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial. ( Barbone, F; De Maria, M; Giannarini, G; Manassero, F; Mogorovich, A; Morelli, G; Selli, C; Valent, F, 2007) |
| "Dan Shao Tang is effective to treatment on simple hematuria of masked nephritis of dificiency of Yin with damp-heat symptom effectively." | 2.70 | [The clinical study on Dan Shao Tang in treating simple hematuria of masked nephritis of deficiency of Yin with damp-heat symptom]. ( Li, J; Mo, S; Shen, W; Wu, X, 2002) |
| " Microscopic hematuria was the most frequent (20%) adverse clinical event, but was unrelated to the INR." | 2.67 | Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group. ( Comp, PC; Durica, SS; Goodman, SG; Gray, RJ; Hall, JH; Hua, TA; Kelley, RP; Langer, A; Lee, RJ; Raskob, GE, 1994) |
| "The diagnosis of incomplete Kawasaki disease was confirmed based on clinical grounds supported by investigations and exclusion of differential diagnosis." | 1.91 | Atypical Kawasaki disease presenting with macroscopic hematuria in an infant: a case report. ( Dayasiri, K; Ragunathan, IR; Thadchanamoorthy, V, 2023) |
| "His course was complicated by cytokine storm and COVID-19-associated coagulopathy." | 1.56 | Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device. ( Estep, J; Hodges, K; Hsich, E; Insler, J; Insler, S; Mubashir, M; Soltesz, E; Tong, M, 2020) |
| "We enrolled 35 patients with MPGN type 1 who had a normal creatinine clearance at the time of their first renal biopsy and divided them into 2 groups based on clinical status at the time of their most recent examination: 12 patients with normal urine test results and 12 patients with minor urinary abnormalities at the latest observation (group 1) and 7 patients with persistent nephropathy and 4 patients with renal insufficiency (group 2)." | 1.33 | Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1. ( Hosoya, M; Isome, M; Kawasaki, Y; Suzuki, H; Takahashi, A; Tanji, M, 2005) |
| "Acute in-stent thrombosis is a well-known complication of carotid angioplasty and stenting (CAS) and often due to resistance to or inadequate treatment with platelet-inhibiting agents." | 1.33 | Late in-stent thrombosis following carotid angioplasty and stenting. ( Buhk, JH; Knauth, M; Wellmer, A, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (33.33) | 18.7374 |
| 1990's | 3 (7.69) | 18.2507 |
| 2000's | 12 (30.77) | 29.6817 |
| 2010's | 7 (17.95) | 24.3611 |
| 2020's | 4 (10.26) | 2.80 |
| Authors | Studies |
|---|---|
| Thadchanamoorthy, V | 1 |
| Dayasiri, K | 1 |
| Ragunathan, IR | 1 |
| Jovanovic, M | 1 |
| Sabovic, M | 1 |
| Hodges, K | 1 |
| Mubashir, M | 1 |
| Insler, J | 1 |
| Estep, J | 1 |
| Hsich, E | 1 |
| Tong, M | 1 |
| Insler, S | 1 |
| Soltesz, E | 1 |
| Chen, D | 1 |
| Liu, G | 1 |
| Xie, Y | 1 |
| Chen, C | 1 |
| Luo, Z | 1 |
| Liu, Y | 1 |
| Tillman, H | 1 |
| Johnston, SC | 1 |
| Farrant, M | 1 |
| Barsan, W | 1 |
| Elm, JJ | 1 |
| Kim, AS | 1 |
| Lindblad, AS | 1 |
| Palesch, YY | 1 |
| Easton, JD | 1 |
| Yamada, S | 1 |
| Yotsueda, H | 1 |
| Nagara, T | 1 |
| Goto, K | 1 |
| Nakashima, Y | 1 |
| Hirakata, H | 1 |
| Fujimi, S | 1 |
| Tsuruya, K | 1 |
| Jeong, CW | 1 |
| Lee, S | 1 |
| Byun, SS | 1 |
| Lee, DH | 1 |
| Lee, SE | 1 |
| Murray, AM | 1 |
| Keville, N | 1 |
| Gray, S | 1 |
| Korsaga-Somé, N | 1 |
| Maruani, A | 1 |
| Abdo, I | 1 |
| Favrais, G | 1 |
| Lorette, G | 1 |
| Carmignani, L | 1 |
| Picozzi, S | 1 |
| Bozzini, G | 1 |
| Negri, E | 1 |
| Ricci, C | 1 |
| Gaeta, M | 1 |
| Pavesi, M | 1 |
| Scharwächter, C | 1 |
| Hanfland, V | 1 |
| Haage, P | 1 |
| Maan, Z | 1 |
| Cutting, CW | 1 |
| Patel, U | 1 |
| Kerry, S | 1 |
| Pietrzak, P | 1 |
| Perry, MJ | 1 |
| Kirby, RS | 1 |
| ANGERVALL, L | 1 |
| LEHMANN, L | 1 |
| BENGTSSON, U | 1 |
| CROCCO, JA | 1 |
| FORMATO, AA | 1 |
| WISING, P | 1 |
| Wu, X | 1 |
| Li, J | 1 |
| Mo, S | 1 |
| Shen, W | 1 |
| Kawasaki, Y | 1 |
| Hosoya, M | 1 |
| Takahashi, A | 1 |
| Isome, M | 1 |
| Tanji, M | 1 |
| Suzuki, H | 1 |
| Ihezue, CU | 1 |
| Smart, J | 1 |
| Dewbury, KC | 2 |
| Mehta, R | 1 |
| Burgess, L | 1 |
| Hurlen, M | 1 |
| Eikvar, L | 1 |
| Seljeflot, I | 1 |
| Arnesen, H | 1 |
| Buhk, JH | 1 |
| Wellmer, A | 1 |
| Knauth, M | 1 |
| Topakian, R | 1 |
| Nussbaumer, K | 1 |
| Trenkler, J | 1 |
| Aichner, FT | 1 |
| Ehrlich, Y | 1 |
| Yossepowitch, O | 1 |
| Margel, D | 1 |
| Lask, D | 1 |
| Livne, PM | 1 |
| Baniel, J | 1 |
| Giannarini, G | 1 |
| Mogorovich, A | 1 |
| Valent, F | 1 |
| Morelli, G | 1 |
| De Maria, M | 1 |
| Manassero, F | 1 |
| Barbone, F | 1 |
| Selli, C | 1 |
| Halliwell, OT | 1 |
| Yadegafar, G | 1 |
| Lane, C | 1 |
| Walker, AM | 1 |
| Jick, H | 1 |
| Goodman, SG | 1 |
| Langer, A | 1 |
| Durica, SS | 1 |
| Raskob, GE | 1 |
| Comp, PC | 1 |
| Gray, RJ | 1 |
| Hall, JH | 1 |
| Kelley, RP | 1 |
| Hua, TA | 1 |
| Lee, RJ | 1 |
| Toupin, LR | 1 |
| Blanchard, DG | 1 |
| Avidor, Y | 1 |
| Nadu, A | 1 |
| Matzkin, H | 1 |
| Zaman, Z | 1 |
| Roggeman, S | 1 |
| Cappelletti, P | 1 |
| Ferrai, G | 1 |
| Buxeda, M | 1 |
| Barba, N | 1 |
| Szer, IS | 1 |
| Goldenstein-Schainberg, C | 1 |
| Kurtin, PS | 1 |
| Sutor, AH | 1 |
| Schindera, F | 1 |
| Jacobi, H | 1 |
| Künzer, W | 1 |
| Burry, HC | 1 |
| Hawtrey, CE | 1 |
| Williams, JJ | 1 |
| Schmidt, JD | 1 |
| Huttman, DH | 1 |
| Abrahams, C | 1 |
| Levinson, C | 1 |
| Adam, WR | 1 |
| Dawborn, JK | 1 |
| Price, CG | 1 |
| Riddell, J | 1 |
| Story, H | 1 |
| Randall, RE | 1 |
| Stacy, WK | 1 |
| Toone, EC | 1 |
| Prout, GR | 1 |
| Madge, GE | 1 |
| Shadomy, HJ | 1 |
| Shadomy, S | 1 |
| Utz, JP | 1 |
| McMillan, JM | 1 |
| Lawson, DH | 1 |
| Paton, AM | 1 |
| Linton, AL | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial[NCT00991029] | Phase 3 | 4,881 participants (Actual) | Interventional | 2010-05-28 | Terminated (stopped due to The trial was halted by the DSMB.) | ||
| To Investigate Post-procedure Hemorrhage and Cardiovascular Events in Taiwanese Patients Who Continue or Discontinue Low-Dose Aspirin Before Transrectal Prostate Biopsy: a Prospective Randomized Trial[NCT02744937] | Phase 4 | 150 participants (Anticipated) | Interventional | 2016-04-30 | Not yet recruiting | ||
| Must Aspirin be Discontinued Prior to TURBT: a Prospective, Randomized, Non-inferiority Trial Comparing Peri-operative Aspirin Continuation Versus Discontinuation.[NCT02350543] | Phase 4 | 50 participants (Actual) | Interventional | 2015-02-28 | Terminated (stopped due to Insufficient recruitment.) | ||
| [NCT00000482] | Phase 3 | 0 participants | Interventional | 1965-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Secondary efficacy outcome: Number of participants with ischemic stroke, myocardial infarction, death from ischemic vascular causes, or major hemorrhage (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 141 |
| Placebo | 167 |
Primary efficacy outcome: Number of Participants with Ischemic Stroke, Myocardial Infarction, or Death From Ischemic Vascular Causes (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 121 |
| Placebo | 160 |
Other safety outcome: Number of Participants with Death from any cause (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 18 |
| Placebo | 12 |
Secondary efficacy outcome: Number of participants with Death from ischemic vascular causes (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 6 |
| Placebo | 4 |
Other safety outcome: Number of participants with Hemorrhagic stroke (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 5 |
| Placebo | 3 |
Secondary efficacy outcome: Number of participants with Ischemic or hemorrhagic stroke (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 116 |
| Placebo | 156 |
Secondary efficacy outcome:Number of participants with Ischemic stroke (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 112 |
| Placebo | 155 |
Primary safety outcome: Number of Participants with major hemorrhage (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 23 |
| Placebo | 10 |
Other safety outcome: Number of Participants with Major hemorrhage other than intracranial hemorrhage (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 17 |
| Placebo | 7 |
Other safety outcome:Number of Participants with Minor hemorrhage (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 40 |
| Placebo | 13 |
Secondary efficacy outcome: Number of participants with Myocardial infarction (NCT00991029)
Timeframe: Up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 10 |
| Placebo | 7 |
Other safety outcome: Number of participants with other symptomatic intracranial hemorrhage (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 2 |
| Placebo | 0 |
Other safety outcome: Number of participants with Symptomatic intracerebral hemorrhage (NCT00991029)
Timeframe: up to 90 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Clopidogrel | 2 |
| Placebo | 2 |
3 reviews available for aspirin and Hematuria
| Article | Year |
|---|---|
Refractory drug-induced systemic small-vessel vasculitis with two varied extracutaneous manifestations: a case report and review of the literature.
Topics: Aspirin; Clopidogrel; Hematuria; Humans; Immunoglobulin E; Male; Naproxen; Ticagrelor; Vasculitis; Y | 2023 |
Safety of transrectal ultrasound-guided prostate biopsy in patients receiving aspirin: An update meta-analysis including 3373 patients.
Topics: Aspirin; Biopsy, Needle; Clinical Trials as Topic; Gastrointestinal Hemorrhage; Hematuria; Hemosperm | 2021 |
Transrectal ultrasound-guided prostate biopsies in patients taking aspirin for cardiovascular disease: A meta-analysis.
Topics: Aspirin; Biopsy; Cardiovascular Diseases; Hematuria; Hemorrhage; Hemospermia; Humans; Male; Platelet | 2011 |
7 trials available for aspirin and Hematuria
| Article | Year |
|---|---|
Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.
Topics: Aged; Aspirin; Brain Ischemia; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; | 2019 |
[The clinical study on Dan Shao Tang in treating simple hematuria of masked nephritis of deficiency of Yin with damp-heat symptom].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aspirin; Dipyridamole; Drug Combinations; Drug Therapy, C | 2002 |
Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis.
Topics: Anticoagulants; Aspirin; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; | 2006 |
Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Cystoscopy; Drug Administration Schedule; Female; Fibrinolytic Age | 2007 |
Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Cystoscopy; Drug Administration Schedule; Female; Fibrinolytic Age | 2007 |
Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Cystoscopy; Drug Administration Schedule; Female; Fibrinolytic Age | 2007 |
Early initiation of aspirin after prostate and transurethral bladder surgeries is not associated with increased incidence of postoperative bleeding: a prospective, randomized trial.
Topics: Aged; Aged, 80 and over; Aspirin; Cystoscopy; Drug Administration Schedule; Female; Fibrinolytic Age | 2007 |
Continuing or discontinuing low-dose aspirin before transrectal prostate biopsy: results of a prospective randomized trial.
Topics: Aged; Aspirin; Biopsy, Needle; Follow-Up Studies; Gastrointestinal Hemorrhage; Hematuria; Hemospermi | 2007 |
Aspirin in coronary heart disease. The Coronary Drug Project Research Group.
Topics: Aspirin; Clinical Trials as Topic; Coronary Disease; Double-Blind Method; Hematuria; Humans; Hyperte | 1980 |
Safety and anticoagulation effect of a low-dose combination of warfarin and aspirin in clinically stable coronary artery disease. Coumadin Aspirin Reinfarction (CARS) Pilot Study Group.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Blood Coagulation; Coronary Disease; Drug Administ | 1994 |
29 other studies available for aspirin and Hematuria
| Article | Year |
|---|---|
Atypical Kawasaki disease presenting with macroscopic hematuria in an infant: a case report.
Topics: Aspirin; Child; Child, Preschool; Fever; Hematuria; Humans; Immunoglobulins, Intravenous; India; Inf | 2023 |
Successful management of COVID-19 and associated coagulopathy in a patient with durable left ventricular assist device.
Topics: Adult; Anticoagulants; Aspirin; Biomarkers; Blood Transfusion; COVID-19; Cytokine Release Syndrome; | 2020 |
Heterochronic spontaneous rupture of bilateral renal cell carcinomas in a hemodialysis patient.
Topics: Anemia; Aspirin; Blood Transfusion; Carcinoma, Renal Cell; Glomerulonephritis; Hematuria; Humans; Ki | 2013 |
No increase in risk of microscopic hematuria with aspirin use by asymptomatic healthy people.
Topics: Adult; Age Factors; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cross-Sectional Studies; | 2013 |
A cautionary tale on the use of antiplatelet treatment following TURP.
Topics: Aged; Aspirin; Clopidogrel; Coronary Thrombosis; Drug-Eluting Stents; Hematuria; Humans; Male; Myoca | 2014 |
[Kasabach-Merritt phenomenon (KMP) exacerbated by platelet transfusions].
Topics: Aspirin; Axilla; Combined Modality Therapy; Compression Bandages; Disease Progression; Disseminated | 2015 |
[Acute analgesic-induced renal papillary necrosis].
Topics: Analgesics; Aspirin; Diagnosis, Differential; Dose-Response Relationship, Drug; Female; Headache; He | 2013 |
Morbidity of transrectal ultrasonography-guided prostate biopsies in patients after the continued use of low-dose aspirin.
Topics: Aspirin; Biopsy, Needle; Blood; Cohort Studies; Gastrointestinal Hemorrhage; Hematuria; Hemorrhage; | 2003 |
THE RENAL CONCENTRATING CAPACITY IN ALBINO RATS AFTER LONG-TERM CONSUMPTION OF PHENACETIN, NAPA (N-ACETYL-P-AMINOPHENOL) AND ACETYLSALICYLIC ACID.
Topics: Acetaminophen; Analgesics; Analgesics, Non-Narcotic; Antipyretics; Aspirin; Body Weight; Erythrocyte | 1964 |
GROSS HEMATURIA AS A PRESENTING MANIFESTATION OF REITER'S SYNDROME IN A WOMAN.
Topics: Analgesics; Anti-Bacterial Agents; Arthritis, Reactive; Aspirin; Dextropropoxyphene; Female; Hematur | 1964 |
Hematuria, hypoprothrombinemia and salicylate medication.
Topics: Aspirin; Hematuria; Hemostatics; Humans; Hypoprothrombinemias; Prothrombin; Salicylates | 1952 |
Myeloid-related protein 8 expression on macrophages is a useful prognostic marker for renal dysfunction in children with MPGN type 1.
Topics: Adolescent; Aspirin; Biomarkers; Biopsy; Calgranulin A; Calgranulin B; Child; Creatinine; Cyclophosp | 2005 |
Biopsy of the prostate guided by transrectal ultrasound: relation between warfarin use and incidence of bleeding complications.
Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Biopsy; Blood; Fibrinolytic Agents; Follow-Up Stud | 2005 |
Late in-stent thrombosis following carotid angioplasty and stenting.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Angioplasty, Balloon; Anticoagulants; Aph | 2006 |
Late in-stent thrombosis following carotid angioplasty and stenting.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Angioplasty, Balloon; Anticoagulants; Aph | 2007 |
Transrectal ultrasound-guided biopsy of the prostate: aspirin increases the incidence of minor bleeding complications.
Topics: Aged; Aspirin; Biopsy; Case-Control Studies; Hematuria; Hemospermia; Humans; Male; Platelet Aggregat | 2008 |
Predictors of bleeding during heparin therapy.
Topics: Adult; Aged; Alcohol Drinking; Aspirin; Dose-Response Relationship, Drug; Epistaxis; Female; Hematom | 1980 |
Acute anuric renal failure: a complication of combined thrombolytic and antithrombotic therapy.
Topics: Acute Kidney Injury; Angioplasty, Balloon, Coronary; Anuria; Aspirin; Combined Modality Therapy; Dru | 1993 |
Clinical significance of gross hematuria and its evaluation in patients receiving anticoagulant and aspirin treatment.
Topics: Aged; Anticoagulants; Aspirin; Female; Hematuria; Humans; Male; Retrospective Studies; Warfarin | 2000 |
Evaluation of Aution Max AX-4280 automated urine test-strip analyser.
Topics: Ascorbic Acid; Aspirin; Chemistry, Clinical; Glucose; Hematuria; Humans; Hydrogen-Ion Concentration; | 2001 |
Paucity of renal complications associated with nonsteroidal antiinflammatory drugs in children with chronic arthritis.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Juvenile; Aspirin; Child; Child, Pre | 1991 |
Haemolytic-uraemic syndrome: thrombocyturia after treatment with streptokinase and aspirin.
Topics: Anemia, Hemolytic; Aspirin; Blood Cell Count; Blood Platelets; Child; Hematuria; Hemolytic-Uremic Sy | 1972 |
Drug-induced nephropathies.
Topics: Animals; Arthritis, Rheumatoid; Aspirin; Colic; Complement System Proteins; Glomerular Filtration Ra | 1973 |
Cystitis emphysematosa.
Topics: Adult; Aspirin; Cephalexin; Cystitis; Cystoscopy; Diabetes Complications; Diabetes Mellitus; Diet, D | 1974 |
[Aspirin in the treatment of myocardial infarct].
Topics: Aspirin; Bicarbonates; Blood Coagulation; Blood Sedimentation; Gastrointestinal Diseases; Hematuria; | 1971 |
Ultrastructure of the renal papilla in experimentally induced analgesic nephritis in rats.
Topics: Analgesics; Animals; Aspirin; Blood Platelets; Caffeine; Hematuria; Kidney; Kidney Tubules; Male; Mi | 1970 |
Anaplastic transitional-cell carcinoma of the renal pelvis in association with analgesic abuse.
Topics: Adult; Anuria; Aspirin; Autopsy; Blood Chemical Analysis; Caffeine; Carcinoma, Transitional Cell; Fe | 1970 |
Cryptococcal pyelonephritis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Amphotericin B; Arthritis, Rheumatoid; Aspirin; Cryptococcosis | 1968 |
The occurrence and clinical features of analgesic abuse in Western Scotland.
Topics: Adult; Aged; Anemia, Hemolytic; Anemia, Hypochromic; Anemia, Sideroblastic; Aspirin; Blood Urea Nitr | 1968 |